Edmund Optics (EO), a provider of optical components,
introduces its new TECHSPEC High Resolution Large Format Lenses. The lenses cover up to
a 62 mm large format sensor to accommodate a wide variety of applications.

RICHMOND, Calif., Oct. 21 /- Lumiphore Inc., a biotechnology leader in new proprietary bifunctional metal-chelation technology for use in high-value imaging, diagnostics, and therapeutics and Algeta ASA (OSE:ALGETA), the cancer therapeutics company, announced that they have signed a...

OAKLAND, N.J., Oct. 21 /- Collagen Matrix, Inc., the leader in collagen- and mineral-based matrix engineering, announced today that it is expanding its operations by the addition of a 28,000 sq. ft. facility at 15 Thornton Road, Oakland, New Jersey 07436. The company will be relocating...

TORONTO, Oct. 21 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, while Canada typically mimics US trends in the North American dental implant market, last year was very different. The struggling American economy led to a...

WEBSTER, Texas, Oct. 21 /- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced another step in the implementation of its strategy to expand its product line for treating patients...

WASHINGTON, Oct. 21 /- Danaher Corporation (NYSE: DHR ) announced today that GAAP net earnings for the quarter ended October 1, 2010 were $646.4 million, or $0.95 per diluted share, which includes a $0.34 gain related to the formation of the Apex Tool Group joint venture, and represents a...

Tiny wound-up circular bits of DNA that carry a short "hairpin" of RNA could prove a solution to the quest for a non-toxic, long-lived gene therapy vector designed to silence cancer genes in tumor cells, said researchers from Baylor College of Medicine and The Methodist Hospital Research...

(University of Washington) A University of Washington Medical Center patient on Thursday, Oct. 21, will be the world's first recipient of a device that aims to quell the disabling vertigo associated with Meniere's disease. The UW Medicine clinicians who developed the implantable device...